According to a media release from Zimmer Biomet, the acquisition of LDR aims to bolster Zimmer Biomet’s presence in the global spine market and provide the company with an immediate and a leading position in the fast-growing cervical disc replacement (CDR) and MIS segments.
“This highly strategic and complementary transaction will enhance Zimmer Biomet’s innovation leadership in musculoskeletal healthcare by adding a premier spine platform to our portfolio of solutions,” says David Dvorak, president and CEO of Zimmer Biomet, in the release.
“This combination is consistent with our goal of driving meaningful growth across all musculoskeletal markets with innovative products, technologies and services that enhance patient outcomes,” he adds.
“We are delighted with this combination, which will further our commitment to improving spine care by providing greater access to our innovative product offerings for patients around the world, while offering our stockholders immediate cash value,” states Christophe Lavigne, Co-Founder, Chairman, President and CEO of LDR, in the release.
For more information, visit Zimmer Biomet.
[Source(s): Zimmer Biomet Holdings Inc, PR Newswire]